As the living standard in China has been increasing steadily with a growing aging population, the nutraceutical market in China is expanding at an unprecedented speed. In China, nutraceutical products are regulated by the National Medical Products Administration (NMPA), governed by the State Administration for Market Regulation (SAMR). The registered nutraceutical products are eligible to use the “blue hat” icon on the packaging and allowed to claim the approved functions and benefits.


On Oct 15, 2018,  in order to lighten the burden of national basic medical insurance, the General Office of the State Council, National Healthcare Security Administration, National Health Commission, and National Medical Products Administration together established the Joint Procurement Office – published the Paper on Centralized Drug Procurement in “4+7 Cities”.